Professional Overview

Gabrielle Mears is a seasoned healthcare professional currently serving as the Director of Oncology International Market Access & Pricing at AbbVie in the United States. Her key expertise areas include market access, pricing, policy, and strategy, with a focus on the oncology and pharmaceutical industries.

Experience Summary

Current Role

As the Director of Oncology International Market Access & Pricing, Gabrielle's current position involves leading market access and pricing strategies for oncology products internationally. Her key responsibilities include developing and implementing global pricing and market access plans, collaborating with cross-functional teams, and analyzing market trends to inform business decisions. While specific achievements in this role are not detailed, her experience in similar positions suggests a strong ability to drive business growth and improve patient access to treatments.

Career Progression

Gabrielle's career has been marked by progressive leadership roles in the pharmaceutical industry. Notable previous roles include Head of Market Access & Head of Policy at AbbVie, Senior Manager of Policy & Strategy at AbbVie, Vaccines Commercialisation Lead at MSD, and Associate Director of Market Access & New Product Lead at MSD. Her career trajectory demonstrates growth from analytical and associate roles to senior leadership positions, indicating a strong capacity for strategic planning, team leadership, and industry impact.

Academic Background

While specific details on Gabrielle's highest level of education and relevant specializations are not provided, her professional background suggests a strong foundation in health economics, epidemiology, and possibly business administration, given her roles and responsibilities.

Areas of Expertise

Gabrielle's areas of expertise include:

• Industry-specific skills: Market access, pricing, policy, strategy, and commercialization in the pharmaceutical and oncology sectors.

• Technical competencies: Health economics, outcomes research, and epidemiology.

• Leadership and management capabilities: Proven ability to lead cross-functional teams, develop and implement global strategies, and drive business growth.

Professional Impact

Gabrielle's professional impact is evident through her contributions to the development and implementation of market access and pricing strategies that improve patient access to treatments. While specific projects or initiatives are not detailed, her leadership roles and industry focus suggest a commitment to advancing healthcare outcomes through strategic business practices.

Conclusion

Gabrielle Mears' professional trajectory underscores her expertise in market access, pricing, and strategy within the pharmaceutical industry, particularly in oncology. Her current focus on leading international market access and pricing efforts at AbbVie positions her as a key figure in shaping global healthcare outcomes. With a strong background in health economics and leadership, Gabrielle offers a unique value proposition: the ability to bridge business strategy with patient needs, driving growth while enhancing access to critical treatments.